Casgevy and Lyfgenia – why they are milestones and why they are just milestones
On December 8th, the U.S. Food and Drug Administration (FDA) approved two groundbreaking therapeutic drugs, Casgevy (developed jointly by Vertex
Continue readingCasgevy and Lyfgenia – why they are milestones and why they are just milestones